Técnicos especialistas en radiodiagnóstico del Instituto Catalán de la Salud PDF Download
Are you looking for read ebook online? Search for your book and save it on your Kindle device, PC, phones or tablets. Download Técnicos especialistas en radiodiagnóstico del Instituto Catalán de la Salud PDF full book. Access full book title Técnicos especialistas en radiodiagnóstico del Instituto Catalán de la Salud by Luis del Castillo Torres. Download full books in PDF and EPUB format.
Author: Luis del Castillo Torres
Publisher:
ISBN: 9788466529723
Category :
Languages : es
Pages : 240
Get Book Here
Book Description
Author: Luis del Castillo Torres
Publisher:
ISBN: 9788466529723
Category :
Languages : es
Pages : 240
Get Book Here
Book Description
Author: Comité de Expertos de la OMS en servicios de Laboratorio de Salud Pública
Publisher:
ISBN:
Category :
Languages : es
Pages : 32
Get Book Here
Book Description
Author: Comité de Expertos de la OMS en servicios de Laboratorio de Salud Pública
Publisher:
ISBN:
Category :
Languages : es
Pages : 0
Get Book Here
Book Description
Author: María José de Benavides Gómez
Publisher:
ISBN: 9788480617697
Category : Education
Languages : es
Pages : 262
Get Book Here
Book Description
Author:
Publisher:
ISBN:
Category : Communicable diseases
Languages : en
Pages : 696
Get Book Here
Book Description
Author:
Publisher:
ISBN:
Category : Gazettes
Languages : en
Pages : 1002
Get Book Here
Book Description
Author: Organizer Committee IPAP18 – Salamanca
Publisher: Ediciones Universidad de Salamanca
ISBN: 8490129762
Category : Medical
Languages : es
Pages : 358
Get Book Here
Book Description
This book contains the summaries of the "Innovation in Pharmacy: Advances and Perspectives" that took place in Salamanca (Spain) in September 2018. The early science of chemistry and microbiology were the source of most drugs until the revolution of genetic engineering in the mid 1970s. Then biotechnology made available novel protein agents such as interferons, blood factors and monoclonal antibodies that have changed the modern pharmacy. Over the past year, a new pharmacy of oligonucleotides has emerged from the science of gene expression such as RNA splicing and RNA interference. The ability to design therapeutic agents from genomic sequences will transform treatment for many diseases. The science that created this advance and its future promise will be discussed. Phillip Allen Sharp is an American geneticist and molecular biologist who co-discovered RNA splicing. He shared the 1993 Nobel Prize in Physiology or Medicine with Richard J. Roberts for “the discovery that genes in eukaryotes are not contiguous strings but contain introns, and that the splicing of messenger RNA to delete those introns can occur in different ways, yielding different proteins from the same DNA sequence. He works in Institute Professor Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology (MIT), Cambridge, MA, US. Este libro recoge los resúmenes de la «Innovation in Pharmacy: Advances and Perspectives» que tuvo lugar en Salamanca (España) en septiembre de 2018. La ciencia primitiva de la química y la microbiología fue la fuente de la mayoría de las drogas hasta la revolución de la ingeniería genética a mediados de la década de 1970. Luego, la biotecnología puso a disposición agentes proteínicos novedosos como interferones, factores sanguíneos y anticuerpos monoclonales que han cambiado la farmacia moderna. Durante el año pasado, surgió una nueva farmacia de oligonucleótidos a partir de la ciencia de la expresión génica, como el empalme de ARN y la interferencia de ARN. La capacidad de diseñar agentes terapéuticos a partir de secuencias genómicas transformará el tratamiento de muchas enfermedades. La ciencia que creó este avance y su promesa futura será discutida. Phillip Allen Sharp es un genetista y biólogo molecular estadounidense que co-descubrió el empalme de ARN. Compartió el Premio Nobel de 1993 en Fisiología o Medicina con Richard J. Roberts por "el descubrimiento de que los genes en eucariotas no son cadenas contiguas, sino que contienen intrones, y que el empalme del ARN mensajero para eliminar esos intrones puede ocurrir de diferentes maneras, produciendo diferentes proteínas de la misma secuencia de ADN. Trabaja en el Instituto Profesor Koch Institute for Integrative Cancer Research, Instituto Tecnológico de Massachusetts (MIT), Cambridge, MA, EE. UU.
Author: Joaquín Barraquer
Publisher:
ISBN:
Category : Eye
Languages : en
Pages : 264
Get Book Here
Book Description
Author:
Publisher:
ISBN:
Category :
Languages : en
Pages : 2422
Get Book Here
Book Description
Author: Juan E. del Llano-Señarís
Publisher: Springer
ISBN: 3319150049
Category : Business & Economics
Languages : en
Pages : 164
Get Book Here
Book Description
This book disentangles the issues in connection with the advancement of Health Technology Assessment (HTA) and its interface with health policy. It highlights the factors that should shape its progress in the near future. Interdisciplinary and critical views from a number of professionals are put together in a prescient order to cast some light and make recommendations as to the next steps HTA should take to be fit for purpose. A wealth of documents dealing with HTA have been published over the last three decades. HTA allegedly is one of the bedrocks of regulation and medical decision making. However, counter vailing visions contend that geographical variations in the role that HTA is actually playing within countries pinpoints specific room for improvement. Given our social preferences, cherry-picking HTA’s features and successes over the last decades moves it away from its possibility frontier. Some of the most noteworthy hindrances that HTA faces, in several countries, to making headway towards its consolidation as an efficient tool for regulation and decision making are as follows: insufficient resources, delays in assessment, inadequate priority setting, regulatory capture, public distrust, actual influence on regulatory decisions, the need for strengthening international cooperation and harmony, the lack of sound and consistent assessments of diagnostic tests, medical devices and surgical innovations and limited dissemination. Time has come for HTA to take a renewed stand. There is a pressing need to submit HTA to in-depth critical scrutiny.
